Maryland SB 226: Biotechnology Investment Tax Credit - Qualified Maryland Biotechnology Company - Definition

Status: Approved by the Governor - Chapter 476 (as of 2017-05-04)

State: Maryland · Session: 2017 · Bill: SB 226

Subjects: Taxes - Income, Industry and Technology, Investments, Medical Research, Tax Credits

Sponsors: Manno, DeGrange, Edwards, Feldman, Hough, Kasemeyer, King, Lee, Madaleno, McFadden, Peters, Serafini, Young

View Maryland SB 226 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.